Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Francesco, Pucciarini"'
Autor:
Erminia Ridolo, Cristoforo Incorvaia, Francesco Pucciarini, Elena Makri, Giovanni Paoletti, Giorgio Walter Canonica
Publikováno v:
Clinical and Molecular Allergy, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Introduction Allergic rhinitis (AR) is very commonly caused by pollens. The symptoms of AR consist of sneezing, nasal congestion, rhinorrhea, nasal itching and airflow obstruction. The diagnosis has long been based on clinical history, skin
Externí odkaz:
https://doaj.org/article/72690e4bb25a42298923a1a59530bf6d
Autor:
Eustachio Nettis, Luisa Brussino, Vincenzo Patella, Laura Bonzano, Aikaterini Detoraki, Elisabetta Di Leo, Maria Maddalena Sirufo, Cristiano Caruso, Fabio Lodi Rizzini, Mariaelisabetta Conte, Mona-Rita Yacoub, Massimo Triggiani, Erminia Ridolo, Luigi Macchia, Giovanni Rolla, Raffaele Brancaccio, Amato De Paulis, Giuseppe Spadaro, Danilo Di Bona, Angela Maria D’Uggento, Lia Ginaldi, Francesco Gaeta, Eleonora Nucera, Kliljeda Jaubashi, Danilo Villalta, Lorenzo Dagna, Domenico Ciotta, Francesco Pucciarini, Diego Bagnasco, Giorgio Celi, Fulvia Chieco Bianchi, Lorenzo Cosmi, Maria Teresa Costantino, Maria Angiola Crivellaro, Simona D’Alò, Pietro del Biondo, Stefano Del Giacco, Mario Di Gioacchino, Linda Di Pietro, Elisabetta Favero, Sebastiano Gangemi, Gabriella Guarnieri, Enrico Heffler, Maria Stefania Leto Barone, Carla Lombardo, Francesca Losa, Andrea Matucci, Paola Lucia Minciullo, Paola Parronchi, Giovanni Passalacqua, Stefano Pucci, Oliviero Rossi, Lorenzo Salvati, Michele Schiappoli, Gianenrico Senna, Andrea Vianello, Alessandra Vultaggio, Yang Baoran, Cristoforo Incorvaia, Giorgio Walter Canonica
Publikováno v:
Clinical and Molecular Allergy, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Biologics are currently one of the main treatment options for a number of diseases. The IgG4 monoclonal antibody dupilumab targets the Interleukin-4 receptor alpha chain, thus preventing the biological effects of the cytokines IL-
Externí odkaz:
https://doaj.org/article/c0b587c13e9540b98f41d2d9e2993fb7
Autor:
Erminia Ridolo, Francesco Pucciarini, Paola Kihlgren, Alessandro Barone, Francesca Nicoletta, Silvia Peveri, Marcello Montagni, Cristoforo Incorvaia
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 9, Pp 100683- (2022)
Introduction: Lipid transfer proteins (nsLTPs) are ubiquitous allergens. Patients affected by nsLTP syndrome experience symptoms to various plant-derived foods, ranging from local manifestations to anaphylaxis, the critical treatment of which is repr
Externí odkaz:
https://doaj.org/article/8682149649d64c3caa2a6cf957dbd924
Autor:
Mariabeatrice Bertolani, Maria Beatrice de Felici del Giudice, Erminia Ridolo, Francesco Pucciarini, Claudio Feliciani, Francesca Satolli
Publikováno v:
Dermatology Reports (2022)
Since the beginning of the covid-vaccine campaign, a lot of local and systemic dermatologic reactions happening after the administration of Coronavirus disease 2019 (COVID-19) vaccines have been described, even if their exact biological mechanism is
Externí odkaz:
https://doaj.org/article/a665e01c7fc840418b274221720c73ea
Autor:
Cristoforo Incorvaia, Enrico Heffler, Silvia Peveri, Francesco Pucciarini, Giorgio Walter Canonica, Erminia Ridolo
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
Adherence and compliance, respectively considered as a more positive, proactive behavior, resulting in a patient's lifestyle change to follow a daily regimen, and, as a more enforced response to an external command, are a critical aspect of any medic
Externí odkaz:
https://doaj.org/article/6e2d5d6ae40049fdbeccfb537b01121f
Autor:
Erminia Ridolo, Francesco Pucciarini, Maria Cristina Nizi, Eleni Makri, Paola Kihlgren, Lorenzo Panella, Cristoforo Incorvaia
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 10, Pp 2349-2356 (2020)
The introduction of biologics for the treatment of patients with refractory asthma represented a marked therapeutic advance. For more than 10 y, the only biologic available has been the monoclonal anti-IgE antibody omalizumab, reserved for patients w
Externí odkaz:
https://doaj.org/article/9d1da1ffdf7b48c483b420dc6e3e584b
Autor:
Cristoforo Incorvaia, Erminia Ridolo, Marina Mauro, Francesco Pucciarini, Enrico Heffler, Giorgio Walter Canonica
Publikováno v:
Frontiers in Allergy, Vol 3 (2022)
Allergen immunotherapy (AIT) and venom immunotherapy (VIT) are meant to work on the causes of allergies, respectively, to respiratory allergens and Hymenoptera venom, inducing tolerance to the allergens and modifying the natural history of allergy. B
Externí odkaz:
https://doaj.org/article/9a66e38009774d25b59396cd01cc3e61
Autor:
Giancarlo Altissimi, Erminia Ridolo, Andrea Ciofalo, Carlo Cavaliere, Marco de Vincentiis, Michaela Plath, Francesco Pucciarini, Antonio Greco, Simonetta Masieri, Cristoforo Incorvaia
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 279:2451-2455
Nasal pathologies are characterized by a symptomatology that hardly allows to distinguish allergic rhinitis (AR), non-allergic rhinitis (NAR), and chronic rhinosinusitis (CRS). Nasal cytology (NC) has shown increasing importance in helping the clinic
Publikováno v:
Acta bio-medica : Atenei Parmensis. 93(5)
Autor:
Erminia, Ridolo, Francesco, Pucciarini, Alessandro, Barone, Antonio, Nouvenne, Tiziana, Meschi, Silvia, Peveri, Cristoforo, Incorvaia
Publikováno v:
Acta Bio Medica : Atenei Parmensis
On March 11, 2019 the World Health Organization (WHO) declared Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, as a pandemic. As of 15/01/2021, more than ninety million cases of infections have been confirmed, with almost two million relat